previous compound ID: 138 next compound
InChIKey: AJBBEYXFRYFVNM-UHFFFAOYSA-N
SMILES: CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "E Matthes" "D Rotin" "J Goepp" "R Robert" "DY Thomas" "J Liao" "B Kus" "SD Macknight" "JW Hanrahan"

chemical graph of compound 138





CID is 6603931
synonyms found at PubChem are:
MRS 1754, 264622-58-4, MRS-1754, MRS1754, CHEMBL273807, [3H]MRS1754, [3H]-MRS1754, N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide, N-(4-Cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide, NCGC00015689-01, Lopac-M-6316, D01QYQ, D0NE5P, ATL-GW-8, Lopac0_000729, GTPL449, GTPL453, ATL-GW-22, MLS002153324, AC1O7G54, SCHEMBL1222380, CHEBI:93269, CTK8E7916, AOB5542, ATL-618, ATL-844, DTXSID80424967, AJBBEYXFRYFVNM-UHFFFAOYSA-N, MolPort-023-276-567, HMS2230A06, HMS3268F13, HMS3373J21, ZINC4475274, BDBM50086170, AKOS024457276, AKOS027427086, CCG-204814, EX-3306, NCGC00015689-02, NCGC00015689-03, NCGC00015689-04, NCGC00094075-01, NCGC00094075-02, NCGC00094075-03, SMR001230737, B7173, EU-0100729, M 6316, L000415, SR-01000076213, J-016440, SR-01000076213-1, BRD-K72024482-001-01-3, A2B adenosine receptor antagonists, Adenosine/Ortho-McNeil, A2B adenosine receptor antagonists (oral, asthma/diabetes), Clinical Data, 8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine, A2B adenosine receptor antagonists (oral, asthma/diabetes), Adenosine Therapeutics, (4-Cyano-phenyl)-carbamic acid 4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenyl ester, Acetamide,N-(4-cyanophenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-, N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide, N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide(MRS-1754), N-(4-cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)acetamide